USP 800 The Count Down to Required Compliance

Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health, encompassing oversight for forty-seven hospitals. His practice expertise includes sterile compounding and healthsystem automation. His focus is to automate processes, in a system setting, which allow for a data driven approach to ensure medications are delivered safely, and in a timely manner. 

Nationally, Dr. Hunter serves on the BD Connected Medication Management and SCA Advisory Board’s. In the state of Louisiana, he serves as President-Elect for the LSHP, and as the President of the South-East LSHP local chapter. In this setting, he is an advocate for hospital pharmacist and is striving to increase Louisiana Pharmacist participation in LSHP. 

Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health Discusses USP 800
Dr. Neil Hunter, PharmaD., MBA, BCSCP, is the System Director – Sterile Drug Compounding for Ochsner Health Discusses USP 800

LEARNING OBJECTIVES:

• Discuss the health effects on hazardous drugs on humans
• Describe the practice standards for handling hazardous drugs in healthcare settings
• Evaluate architectural cleanroom designs before construction
• Select cleanroom products appropriate for cleanroom construction

Latest Videos
View all Videos
Executive Insights
Feb 25, 2025
Hinnah Farooqi serves as the Director of Pharmacy at New York Presbyterian in Queens, a diverse hospital with 500 beds. She discusses the hospital's efforts to improve efficiency and patient safety by using more automation, like RFID technology called Intelligard. Hinnah also emphasizes teamwork with the central sterile team and the hospital's focus on developing leaders and improving management skills through partnerships and internal programs.
Feb 25, 2025

Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships. 

Executive Insights
Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.